Consumption of antibiotics in the community and hospital sectors in Latvia
Latvia: Consumption of antibiotics in the community and hospital sectors was 15.4 Per thousand inhabitants in 2024. ▲ Rising
Consumption of antibiotics in the community and hospital sectors in Latvia, 2013–2024
Source: Eurostat. Measured in Per thousand inhabitants.
Analysis
In 2024, consumption of antibiotics in the community and hospital sectors in Latvia stood at 15.4 Per thousand inhabitants. That is the highest value across all 12 years on record.
Compared with earlier readings it is up 3.4% on the previous year and up 18.5% over ten years.
Over the whole period, consumption of antibiotics in the community and hospital sectors in Latvia peaked at 15.4 Per thousand inhabitants in 2024 and was at its lowest, 11.6 Per thousand inhabitants, in 2021.
That places Latvia 25th out of 36 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 12 years of available data.
Consumption of antibiotics in the community and hospital sectors in Latvia, year by year
| Year | Per thousand inhabitants | Change |
|---|---|---|
| 2013 | 13.7 Per thousand inhabitants | — |
| 2014 | 13 Per thousand inhabitants | -5.1% |
| 2015 | 12.6 Per thousand inhabitants | -3.1% |
| 2016 | 13.4 Per thousand inhabitants | +6.3% |
| 2017 | 13.9 Per thousand inhabitants | +3.7% |
| 2018 | 13.8 Per thousand inhabitants | -0.7% |
| 2019 | 13.9 Per thousand inhabitants | +0.7% |
| 2020 | 11.9 Per thousand inhabitants | -14.4% |
| 2021 | 11.6 Per thousand inhabitants | -2.5% |
| 2022 | 14.9 Per thousand inhabitants | +28.4% |
| 2023 | 14.9 Per thousand inhabitants | +0.0% |
| 2024 | 15.4 Per thousand inhabitants | +3.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 13.47 Per thousand inhabitants | 12.6 Per thousand inhabitants | 13.9 Per thousand inhabitants | 7 |
| 2020s | 13.74 Per thousand inhabitants | 11.6 Per thousand inhabitants | 15.4 Per thousand inhabitants | 5 |
Countries ranked near Latvia
More health data for Latvia
- Mortality, morbidity and welfare cost from exposure to 1.12 Per 1 000 inhabitants (2019)
- Infant mortality rates by NUTS 2 region 1.5 Rate (2024)
- Life expectancy by age, sex and NUTS 2 region 76.4 Year (2024)
- Infant mortality by NUTS 2 region 19 Number (2024)
- Life expectancy — Life expectancy difference -9.8 Years (2024)
- Life expectancy — Life expectancy difference 9.8 Years (2024)
- Life expectancy 76.4 Years (2024)
- Infant health: low birthweight 4.2 Percentage of live births (2024)
- Health personnel by NUTS 2 region - historical data 6,253 Number (2019)
- Hospital beds by NUTS 2 region - historical data 10,379 Number (2019)
Frequently asked questions
- What is consumption of antibiotics in the community and hospital sectors in Latvia?
- Consumption of antibiotics in the community and hospital sectors in Latvia was 15.4 Per thousand inhabitants in 2024, according to Eurostat.
- What is the highest consumption of antibiotics in the community and hospital sectors recorded in Latvia?
- The highest recorded value was 15.4 Per thousand inhabitants in 2024.
- What is the lowest consumption of antibiotics in the community and hospital sectors recorded in Latvia?
- The lowest recorded value was 11.6 Per thousand inhabitants in 2021.
- How does Latvia rank for consumption of antibiotics in the community and hospital sectors?
- Latvia ranks 25th out of 36 countries with data for 2024.
- Is consumption of antibiotics in the community and hospital sectors rising or falling in Latvia?
- Over the last ten years it is up 18.5%. The long-run trend across the full record is rising.
- Where does this Latvia data come from?
- The figures come from Eurostat, published as part of Consumption of antibiotics in the community and hospital sectors - defined daily doses (DDD) per day. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY 4.0 (Eurostat).